Clinical Trial Update: Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Pfizer-sponsored Phase 1/2 trial evaluated the efficacy of combining axitinib with pemetrexed and cisplatin in non-squamous non-small cell lung cancer; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• CISPLATIN (cisplatin)
• INLYTA (AXITINIB)

Snippet

Sponsor: Pfizer | Conditions: Carcinoma, Non-Small Cell Lung | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-03-30